| Literature DB >> 34200763 |
Mohamed S Hasanin1, Mohamed Abdelraof2, Mohamed Fikry3, Yasser M Shaker4, Ayman M K Sweed4, Mathias O Senge5.
Abstract
The development of new antimicrobial strategies that act more efficiently than traditional antibiotics is becoming a necessity to combat multidrug-resistant pathogens. Here we report the efficacy of laser-light-irradiated 5,10,15,20-tetrakis(m-hydroxyphenyl)porphyrin (mTHPP) loaded onto an ethylcellulose (EC)/chitosan (Chs) nanocomposite in eradicating multi-drug resistant Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. Surface loading of the ethylcelllose/chitosan composite with mTHPP was carried out and the resulting nanocomposite was fully characterized. The results indicate that the prepared nanocomposite incorporates mTHPP inside, and that the composite acquired an overall positive charge. The incorporation of mTHPP into the nanocomposite enhanced the photo- and thermal stability. Different laser wavelengths (458; 476; 488; 515; 635 nm), powers (5-70 mW), and exposure times (15-45 min) were investigated in the antimicrobial photodynamic therapy (aPDT) experiments, with the best inhibition observed using 635 nm with the mTHPP EC/Chs nanocomposite for C. albicans (59 ± 0.21%), P. aeruginosa (71.7 ± 1.72%), and S. aureus (74.2 ± 1.26%) with illumination of only 15 min. Utilization of higher doses (70 mW) for longer periods achieved more eradication of microbial growth.Entities:
Keywords: antimicrobial; chitosan; ethylcellulose; laser light; mTHPP; multidrug resistance; nanocomposite; photodynamic therapy
Mesh:
Substances:
Year: 2021 PMID: 34200763 PMCID: PMC8230394 DOI: 10.3390/molecules26123551
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Design and synthesis of mTHPP EC/Chs nanocomposite for aPDT.
Zeta potential measurements of mTHPP, the mTHPP-loaded nanocomposite, and the free nanocomposite.
| Zeta Potential Measurements | Particle Size Measurements | |||||
|---|---|---|---|---|---|---|
| Sample | Cell Current, mA | Av. Phase Shift, rad/sec | Av. Mobility, M.U. | Av. Zeta Potential, mV | PDI | Average Particle Size, nm |
| 0.65 | 11.82 | 1.44 | −20.55 | 0.137 | 175 | |
| Free composite | 7.34 | 11.02 | 1.67 | 35.5 | 0.245 | 292 |
| 1.65 | 18.2 | 2.48 | 23.84 | 0.442 | 595 | |
Figure 2Polarized microscope image for the mTHPP-loaded nanocomposite. (a) No filter; (b) 530 nm filter; (c) cold blue light; (d) daylight cold blue filter.
Figure 3FT-IR of mTHPP, EC, Chs, free composite, and mTHPP-loaded nanocomposite.
Figure 4XRD pattern of mTHPP, EC, Chs, free composite, and mTHPP-loaded nanocomposite.
Figure 5(a) Porphyrin at low magnification; (b) high magnification; (c) EDX.; (d) Free composite at low magnification; (e) high magnification; (f) EDX.; (g) Loaded nanocomposite at low magnification; (h) high magnification; (i) EDX.; (j) image process of the high magnification loaded nanocomposite SEM image.
Figure 6Absorption spectra (main curves) and the thermal stability of each peak (insert curves) of (a) porphyrin and (b) porphyrin nanocomposite at different temperatures.
Screening of the antimicrobial activity of mTHPP and mTHPP-loaded nanocomposite in the presence and in the absence of red laser light (635 nm).
| Sample | Inhibition in Microbial Survival, % | ||
|---|---|---|---|
|
|
|
| |
| 3.29 ± 0.19 | 2.15 ± 0.20 | 6.28 ± 0.54 | |
| 0.41 ± 0.02 | 0 ± 0 | 2.86 ± 0.11 | |
| 21.76 ± 1.7 | 14.16 ± 0.91 | 10.6 ± 0.56 | |
| 22.63 ± 1.5 | 16.5 ± 0.66 | 13.4 ± 0.40 | |
| Control | 100 | ||
Antimicrobial photodynamic therapy of mTHPP and mTHPP-loaded nanocomposite at different wavelengths.
| Inhibition in | ||||||
|---|---|---|---|---|---|---|
| Wavelength | Laser Only | |||||
| (nm) | Time Exposure (min) | |||||
|
|
|
|
|
|
| |
| 458 | 13.3 ± 0.5 | 23.66 ± 1.45 | 44.03 ± 0.75 | 58.73 ± 1.11 | 21.8 ± 1.02 | 27.26 ± 1.39 |
| 476 | 10.36 ± 0.49 | 15.73 ± 0.87 | 36.03 ± 1.54 | 44.13 ± 0.71 | 21.93 ± 0.89 | 25.96 ± 0.77 |
| 488 | 13.93 ± 1.05 | 18.56 ± 1.14 | 38.33 ± 0.41 | 51.86 ± 0.49 | 17.53 ± 1.23 | 33.16 ± 0.26 |
| 515 | 7.33 ± 0.59 | 13.26 ± 1.47 | 40.1 ± 0.86 | 50.46 ± 0.40 | 31.26 ± 1.01 | 43.33 ± 0.74 |
| 635 | 3.46 ± 0.54 | 7.33 ± 0.94 | 35.06 ± 0.82 | 54.3 ± 0.64 | 59.1 ± 0.21 | 71.13 ± 1.5 |
| Control | 100 | |||||
|
| ||||||
|
|
|
|
| |||
|
|
| |||||
|
|
|
|
|
|
| |
| 458 | 16.4 ± 0.60 | 21.7 ± 0.94 | 40.6 ± 1.22 | 74.4 ± 1.73 | 23.6 ± 1.47 | 32.6 ± 1.46 |
| 476 | 17.8 ± 0.32 | 22.7 ± 0.95 | 54.06 ± 0.82 | 83.4 ± 1.44 | 30.8 ± 1.04 | 38.3 ± 2.02 |
| 488 | 22.1 ± 1.3 | 27.7 ± 1.16 | 47.2 ± 0.55 | 70.6 ± 0.94 | 42.2 ± 2.17 | 56.3 ± 0.65 |
| 515 | 4.4 ± 0.45 | 10.3 ± 0.49 | 49.9 ± 0.91 | 56.7 ± 0.94 | 61.6 ± 0.75 | 72.8 ± 1 |
| 635 | 2.06 ± 0.12 | 7.8 ± 0.32 | 52.3 ± 0.49 | 58.1 ± 3.1 | 74.2 ± 1.26 | 81 ± 2.23 |
| Control | 100 | |||||
|
| ||||||
|
|
|
|
| |||
|
|
| |||||
|
|
|
|
|
|
| |
| 458 | 12.9 ± 1.06 | 34.2 ± 2.99 | 51 ± 2.94 | 79.3 ± 1.6 | 33 ± 1.51 | 36.5 ± 1.89 |
| 476 | 12.1 ± 0.84 | 32.8 ± 0.94 | 53.1 ± 2.31 | 75.9 ± 1.85 | 37.9 ± 2.07 | 43.8 ± 0.94 |
| 488 | 8.2 ± 0.28 | 27.3 ± 1.6 | 65.8 ± 2.23 | 82.2 ± 2.44 | 41.7 ± 1.02 | 53.7 ± 1.40 |
| 515 | 6.5 ± 0.74 | 20.3 ± 1.47 | 52.6 ± 1.94 | 63.8 ± 2.25 | 54.6 ± 1.32 | 63.5 ± 2.2 |
| 635 | 5.5 ± 0.97 | 10.5 ± 0.62 | 36.6 ± 2.27 | 59 ± 2.86 | 71.7 ± 1.72 | 83.1 ± 2.82 |
| Control | 100 | |||||
Antimicrobial photodynamic therapy of mTHPP and the mTHPP-loaded nanocomposite at certain wavelengths with different irradiation powers.
| Power | Inhibition in | |||||
|---|---|---|---|---|---|---|
| Laser Only | ||||||
| Time Exposure (min) | ||||||
|
|
|
|
|
|
| |
| 10 | 12.63 ± 0.70 | 23.36 ± 0.49 | 41.36 ± 1.14 | 60.96 ± 0.78 | 21.8 ± 0.86 | 27.6 ± 1.07 |
| 20 | 19.73 ± 0.65 | 29.2 ± 0.57 | 61.3 ± 0.49 | 72.3 ± 1.02 | 27.93 ± 0.65 | 32.33 ± 0.47 |
| 40 | 22.46 ± 1.1 | 33.26 ± 0.97 | 75.96 ± 0.85 | 77.33 ± 1.69 | 37 ± 1.10 | 41.33 ± 0.49 |
| 70 | 34.4 ± 0.43 | 47.96 ± 0.78 | 83.66 ± 1.24 | 85.2 ± 1.06 | 56.13 ± 0.69 | 60.43 ± 0.40 |
| Control | 100 | |||||
|
|
| |||||
|
|
|
| ||||
|
| ||||||
|
|
|
|
|
|
| |
| 10 | 18.13 ± 0.69 | 23.5 ± 0.57 | 34.71 ± 0.95 | 84.16 ± 0.70 | 23.46 ± 1.30 | 32.73 ± 0.74 |
| 20 | 21.06 ± 0.16 | 30.43 ± 0.75 | 56.3 ± 0.91 | 77.76 ± 1.5 | 35.96 ± 1.36 | 43.36 ± 1.08 |
| 40 | 23.9 ± 0.90 | 31.53 ± 1.12 | 76 ± 0.61 | 81.96 ± 1.36 | 41.26 ± 0.61 | 58.4 ± 0.43 |
| 70 | 30.5 ± 0.57 | 35.16 ± 0.30 | 87.06 ± 0.87 | 88.8 ± 0.69 | 55.56 ± 0.80 | 56.86 ± 1.29 |
| Control | 100 | |||||
|
|
| |||||
|
|
|
| ||||
|
| ||||||
|
|
|
|
|
|
| |
| 10 | 7.9 ± 0.24 | 26.96 ± 1 | 66.5 ± 0.5 | 82.96 ± 1.45 | 31.96 ± 0.85 | 36.8 ± 0.88 |
| 20 | 23.3 ± 0.57 | 36.83 ± 0.93 | 69.9 ± 0.82 | 88.13 ± 0.89 | 42.8 ± 0.88 | 44.43 ± 1.26 |
| 40 | 23.23 ± 1.01 | 37.73 ± 1.06 | 75.9 ± 0.77 | 87.86 ± 0.93 | 50.86 ± 0.69 | 59.4 ± 0.58 |
| 70 | 31.86 ± 0.93 | 44.03 ± 1.29 | 83.4 ± 0.53 | 90.26 ± 0.57 | 59.2 ± 0.90 | 62.26 ± 0.83 |
| Control | 100 | |||||
Figure 7Cytotoxicity of mTHPP and mTHPP-loaded nanocomposite against a Vero normal cell line.